The nomination of Howard Lutnick, chairman and CEO of financial services firm Cantor Fitzgerald, as Commerce Secretary signals a new chapter for the USPTO.
“Issuance of the new patent for our oncology preclinical aPKCi inhibitor pipeline is an important part of our development strategy,” said Jed Latkin, CEO of Windtree Therapeutics. “We will continue ...
Aphios announced today that it was granted US Patent No. 11,981,174 for the thermal conversion of CBDA to CBD and other carboxylic acid cannabinoids to cannabinoids.